» Articles » PMID: 37020110

The Evolution of SARS-CoV-2

Overview
Date 2023 Apr 5
PMID 37020110
Authors
Affiliations
Soon will be listed here.
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence of variants with distinct phenotypes, for example transmissibility, severity and immune evasion. This Review explores the mechanisms that generate genetic variation in SARS-CoV-2, underlying the within-host and population-level processes that underpin these events. We examine the selective forces that likely drove the evolution of higher transmissibility and, in some cases, higher severity during the first year of the pandemic and the role of antigenic evolution during the second and third years, together with the implications of immune escape and reinfections, and the increasing evidence for and potential relevance of recombination. In order to understand how major lineages, such as variants of concern (VOCs), are generated, we contrast the evidence for the chronic infection model underlying the emergence of VOCs with the possibility of an animal reservoir playing a role in SARS-CoV-2 evolution, and conclude that the former is more likely. We evaluate uncertainties and outline scenarios for the possible future evolutionary trajectories of SARS-CoV-2.

Citing Articles

SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy.

Bolis M, Uceda Renteria S, Alagna L, Liparoti A, Passerini B, Pastena A BMC Infect Dis. 2025; 25(1):359.

PMID: 40082784 PMC: 11907959. DOI: 10.1186/s12879-025-10740-w.


Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach.

Mandal S, Chanu W, Natarajaseenivasan K Front Immunol. 2025; 16:1442101.

PMID: 40079004 PMC: 11897530. DOI: 10.3389/fimmu.2025.1442101.


A rapid ecologic analysis, confirmed by a case-control study, identifies class I HLA alleles correlated to the risk of COVID-19.

Correale P, Baglio G, Parrella R, Saladino R, Cuomo N, Scarano F J Transl Med. 2025; 23(1):303.

PMID: 40065352 PMC: 11892203. DOI: 10.1186/s12967-025-06285-w.


Influenza virus evolution and defective genome formation are shaped by host genotype and sex.

Costa R, Acosta-Alvarez L, Curtis K, Zarbock K, Kelleher J, Lamichhane B bioRxiv. 2025; .

PMID: 40060519 PMC: 11888471. DOI: 10.1101/2025.02.26.638946.


Performance assessment of disposable carbon-based immunosensors for the detection of SARS-CoV-2 infections.

Agudelo O, Reyes-Loaiza V, Giraldo-Parra L, Rosales-Chilama M, Perdomo S, Gomez M Sci Rep. 2025; 15(1):7741.

PMID: 40044778 PMC: 11883031. DOI: 10.1038/s41598-025-92104-7.


References
1.
Khare S, Gurry C, Freitas L, Schultz M, Bach G, Diallo A . GISAID's Role in Pandemic Response. China CDC Wkly. 2021; 3(49):1049-1051. PMC: 8668406. DOI: 10.46234/ccdcw2021.255. View

2.
Pybus O, Rambaut A . Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet. 2009; 10(8):540-50. PMC: 7097015. DOI: 10.1038/nrg2583. View

3.
Volz E, Hill V, McCrone J, Price A, Jorgensen D, OToole A . Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity. Cell. 2020; 184(1):64-75.e11. PMC: 7674007. DOI: 10.1016/j.cell.2020.11.020. View

4.
Clarke D, Duarte E, Moya A, Elena S, Domingo E, Holland J . Genetic bottlenecks and population passages cause profound fitness differences in RNA viruses. J Virol. 1993; 67(1):222-8. PMC: 237355. DOI: 10.1128/JVI.67.1.222-228.1993. View

5.
Sanjuan R, Nebot M, Chirico N, Mansky L, Belshaw R . Viral mutation rates. J Virol. 2010; 84(19):9733-48. PMC: 2937809. DOI: 10.1128/JVI.00694-10. View